Differences in extracellular matrix proteins, epidermal growth and differentiation in discoid lupus erythematosus, lichen planus and the overlap syndrome

Acta Dermato-Venereologica

Volumn 77, Issue 5, 1997, Pages 356-360

  De Jong, E M G J ^a   Van Der Vleuten, C J M ^a   Van Vlijmen Willems, I M J J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Heparan sulphate; Immunohistochemistry; Laminin; Tenascin

Indexed keywords

HEPARAN SULFATE; LAMININ; SCLEROPROTEIN; TENASCIN;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; DISCOID LUPUS ERYTHEMATOSUS; EPIDERMIS; EXTRACELLULAR MATRIX; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS; MALE; PRIORITY JOURNAL; SYNDROME;

ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CULTURE TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LICHEN PLANUS; LUPUS ERYTHEMATOSUS, DISCOID; MALE; MIDDLE AGED; SYNDROME;

EID: 0030884157     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Copeman PWM, Schroeter AL, Kierland RR. An unusual variant of lupus erythematosus or lichen planus. Br J Dermatol 1970; 83: 269-272.
2. van der Horst JC, Cirkel PK, Nieboer C. Mixed lichen planus-lupus erythematosus disease: a distinct entity? Clinical, histopathological and immunopathological studies in six patients. Clin Exp Dermatol 1983; 8: 631-640.
3. Camisa C, Neff JC, Olsen RG. Use of indirect immunofluorescence in the lupus erythematosus/lichen planus overlap syndrome: an additional diagnostic clue. J Am Acad Dermatol 1984; 11: 1050-1059.
4. Romero RW, Nesbitt LT, Reed RJ. Unusual variant of lupus erythematosus or lichen planus. Arch Dermatol 1977; 113: 741-748.
5. Plotnick H, Burnham TK. Lichen planus and coexisting lupus erythematosus versus lichen planus-like erythematosus. J Am Acad Dermatol 1986; 14: 931-938.
6. Sundqvist KG, Wanger L. Expression of lymphocyte activation markers in benign cutaneous T-cell infiltrates. Discoid lupus erythematosus versus lichen ruber planus. Acta Derm Venereol (Stockh) 1989; 69: 292-295.
7. Nieboer C. The reality of immunofluorescence and histopathology in the diagnosis of discoid lupus erythematosus and lichen planus. Br J Dermatol 1987; 116: 189-198.
8. Davies MG, Gorkiewicz A, Knight A, Marks R. Is there a relationship between lupus erythematosus and lichen planus? Br J Dermatol 1977; 96: 145-154.
9. Davies MG, Marks R. Evolution of the lesion of discoid lupus erythematosus: a comparison with lichen planus. Br J Dermatol 1977; 97: 313-322.
10. de Jong EMGJ, van Erp PEJ, Ruiter DJ, van de Kerkhof PCM. Immunohistochemical detection of proliferation and differentiation in discoid lupus erythematosus. J Am Acad Dermatol 1991; 25: 1032-1038.
11. Cattoretti G, Becker MHG, Key G. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (Mib-1 and Mib-3) detect proliferating cells in microwave processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357-363.
12. Bauer FW, Boezeman JBM, van Engelen L, de Grood R. Monoclonal antibodies for epidermal population analysis. J Invest Dermatol 1986; 87: 72-75.
13. Weiss RA, Eichner R, Sun TT. Monoclonal antibody analysis of keratin expression in epidermal disease: a 40 and 56 kDalton keratin as markers for hyperproliferative keratinocytes. J Cell Biol 1984; 98: 1397-1406.
14. de Zwart AJ, de Jong EMGJ, van de Kerkhof PCM. Topical application of dithranol on normal skin induces hyperproliferation and increased Ks8.12 binding. Skin Pharmacol 1992; 5: 34-40.
15. Murphy GF, Flynn TC, Rice RH, Pinkers GS. Involucrin expression in normal and neoplastic human skin: a marker for keratinocyte differentiation. J Invest Dermatol 1984; 82: 453-457.
16. Burgeson RE, Chiquet M, Deutzmann R, Ekblom P, Engel J, et al. A new nomenclature for the lamins. Matrix Biology 1994; 14: 209-211.
17. Schalkwijk J, van Vlijmen IMJJ, Oosterling B, Perret C, Koopman RJJ, van den Born J. Tenascin expression in hyperproliferative skin diseases. Br J Dermatol 1991; 124: 13-20.
18. Hardingham T, Fosang AJ. Proteoglycans: many forms and many functions. FASEB J 1992; 6: 861-870.
19. van Duijnhoven JPL, Schalkwijk J, Kranenborg MHBC, van Vlijmen-Willems IMJJ, Groeneveld A, van Erp PEJ. Mon-150: a versatile monoclonal antibody against involucrin. Arch Dermatol Res 1992; 284: 167-172.
20. Potts EDA, Rowell NR. Lichen planus: a distinct entity from lupus erythematosus. Acta Derm Venereol (Stockh) 1981; 61: 413-416.
21. de Jong EMGJ, van de Kerkhof PCM. Co-existence of palmoplantar lichen planus and lupus erythematosus and successful treatment with acitretin. Br J Dermatol, in press.
22. Tammi RH, Hyyryläinen AM, Maibach HI, Tammi MI. Ultrastructural localization of keratinocyte surface associated heparan sulphate proteoglycans in human epidermis. Histochemistry 1987; 87: 243-250.
23. van den Born J, van de Heuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Berden JHM. Monoclonal antibodies against the core protein and the glycosaminoglycan side chain of glomerular basement membrane heparansulphate proteoglycan. Characterization and immunohistochemical application in human tissues. J Histochem Cytochem 1994; 42: 89-102.
24. Martin GR, Rohrbach DH, Terranova VP, Liotta LA. Structure, function and pathology of basement membranes. Monogr Pathol 1983; 24: 16-30.
25. van Vlijmen IMJJ, Mackie EJ, Verstraeten AA, Schalkwijk J. Expression of tenascin in psoriasis and skin tumours. J Invest Dermatol 1990; 95: 494.
26. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988; 107: 2757-2767.
27. van Baar HMJ, Perret C, van Vlijmen-Willems IMJJ, Cleutjens JPM, Mackie EJ, Happle R. Expression of tenascin in perifollicular connective tissue: comparison normal scalp and alopecia areata. Arch Dermatol 1991; 283: 86-90.